2019 HOPE FUNDS FOR CANCER RESEARCH SCIENTIFIC CONVENING
July 26-27, 2019
NEWPORT, RI


For Sponsorship Information, Convening Brochure 2019

Registration is now OPEN, 2019 Registration Form

Agenda available Convening Agenda

 

The aim of the Hope Funds for Cancer Research Scientific Convening is not only to highlight recent exciting advances, but to lay the groundwork for new advances in this field by bringing the best minds in cancer research to facilitate the next golden-age of discoveries and treatments.

TOPICS

cancer cell signaling and transcription
computational biology
condensates/phase separation
RNA, RNAi, mRNA and micro-RNA
metastasis
translation
precision medicine
gene editing

INVITED SPEAKERS
John H. Byrd, Ohio State University
Carlos Campos, University of Washington
Lewis C. Cantley, Weill Cornell Medical School
Don Cleveland, UC San Diego
William C. Hahn, The Broad Institute and Dana-Farber Cancer Institute, KSQ Therapeutics
Robert G. Johnson, Hope Funds SAB member
William Kaelin, Dana-Farber Cancer Institute
Jurre Kamphorst, Rheos Medicines
Carla Kim, Children’s Hospital Boston
Elsa Beyer Krall, Celsius Therapuetics
Jordan Krall, Agios Pharmaceuticals
Robert Langer, Koch Institute for Integrative Cancer Research
Bluma Lesch, Yale University
Leanne Li, Koch Institute for Integrative Cancer Research
Thales Papagiannakopoulos, NYU Medical Center
Christopher Pirozzi, Duke University
Srivatsan Raghavan, Dana-Farber Cancer Institute
Rajesha Rupaimoole, Shepherd Therapeutics
Vicki Sato, Harvard University
Juan Manuel Schvartzman, Memorial Sloan-Kettering

Tuomas Tammela, Memorial Sloan-Kettering Cancer Center
Sohail Tavazoie, Rockefeller University
Bernardo Tavora, Rockefeller University
Craig Thompson, Memorial Sloan-Kettering Cancer Center
Robert A. Weinberg, Whitehead Institute at MIT
Bryan R.G. Williams, Hudson Institute of Medical Research
Johanna Withers, Yale University
currently in formation

CONVENING COMMITTEE
Lewis C. Cantley, Chairman, Hope Funds for Cancer Research
Leah Rush Cann, Trustee, Hope Funds for Cancer Research
Adrian Hobden, Trustee, Hope Funds for Cancer Research
Andrew Mullen, Advisor, Hope Funds for Cancer Research
Chris Pinault, Development Committee, Hope Funds for Cancer Research
currently in formation

ORGANIZED BY:
Hope Funds for Cancer Research: Advancing Innovative Research in Understudied Cancers

The Hope Funds for Cancer Research is a non-profit organization (509 (a)(1) charity under 501(c)(3) of the Internal Revenue Service’s code) that was formed in 2006 by individuals with experience in oncology, intellectual property law, investment banking, philanthropy, sociology, and the arts to fund to the most interesting and promising academic research addressing the most difficult-to-treat cancers. Hope Funds for Cancer Research provides fellowships to postdoctoral scientists who propose to work on highly innovative research projects that challenge the traditional paradigms of understanding the causes, mechanisms, progression, disease markers or risk factors of the most difficult-to-treat cancers, including (but not limited to) pancreatic, lung, liver, sarcomas, esophageal, brain, gastric, bone and ovarian cancers; and rare leukemias, lymphomas and MDS. Proceeds from all Hope Funds for Cancer Research activities, including this convening, support our research Fellows.

www.hope-funds.org

Dinner with the Speakers

Awards Dinner Invitation

Luncheon Invitation